No Data
No Data
No Data
No Data
No Data
MIRA Pharmaceuticals Sees Positive Trial Results for Ketamir-2
By Chris Wack MIRA Pharmaceuticals said it saw positive results in its trial for Ketamir-2, a novel oral ketamine analog that could potentially deliver ultra-rapid antidepressant effects. The pre-cl
WSJApr 2 08:17 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersMSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday's pre-market session. The company's market cap stands at $15.9 million. Serina Therapeutics (AMEX:SER) stock moved up
BenzingaApr 2 08:07 ET
Express News | Mira Pharmaceuticals Highlights Preclinical Ketamir-2 Updates; Says Is Hopeful Results Will Enable Co. To File An NDA With FDA By End Of This Year
Moomoo 24/7Apr 2 08:04 ET
Express News | Mira Pharmaceuticals Q4 EPS $(0.19) Beats $(0.23) Estimate
Moomoo 24/7Apr 2 07:54 ET
GOEV, CHEK and MESO Among Pre-market Losers
Seeking AlphaMar 27 08:28 ET
Press Release: MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor PR Newswire MIAMI, March 21, 2024 A seasoned pharmaceutical industry executiv
Dow JonesMar 21 11:05 ET
Cui Nyonya Kueh : Happy Sunday
Cui Nyonya Kueh : 哥哥 你有养狗吗?
No Data
No Data